To include your compound in the COVID-19 Resource Center, submit it here.

Slaoui resigns from Intellia's board

CRISPR company Intellia Therapeutics Inc. (NASDAQ:NTLA) said Moncef Slaoui resigned

Read the full 109 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE